About Cell Genesys
Cell Genesys is a company based in Hayward (United States) founded in 1988 by Raju Kucherlapati was acquired by BioSante Pharmaceuticals in June 2009. Cell Genesys has raised $310 thousand across 1 funding round from investors including Happy Family Store. Cell Genesys operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Hayward, United States
- Founders Raju Kucherlapati
- SectorsHealthcare
- Website cellgenesys.com
- Social LinkedIn
- Acquired by BioSante Pharmaceuticals (Jun 2009)
- Legal Name Cell Genesys Inc
- Total Equity Funding$310K (USD)
in 1 rounds
- Latest Funding Round$310K (USD), Unspecified
Apr 2009
- Investors
- Acquired byBioSante Pharmaceuticals
(Jun 2009)
Funding Insights of Cell Genesys
Cell Genesys has successfully raised a total of $310K through 1 strategic funding round. The most recent funding activity was a Unspecified round of $310 thousand completed in April 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $310,000
- Total Rounds 1
- Last Round Unspecified — $310,000
- First Round $310,000
(Apr 2009)
All 1 funding rounds of Cell Genesys with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2009 | $310,000 | Unspecified | – | – | – |
1 investors in total: 1 institutional.
Investors in Cell Genesys
Cell Genesys has secured backing from 1 investor. Prominent investors backing the company include Happy Family Store.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Happy Family Store is engaged in developing and distributing medications. | 1998 | biosantepharma.com | Lincolnshire, United States |
Investor details for Cell Genesys
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cell Genesys
1 people are tracked at Cell Genesys (1 in leadership).
| Name | Role | Group |
|---|---|---|
Raju Kucherlapati | Co-Founder | Leadership |
Complete people profiles for Cell Genesys
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cell Genesys
3 dated milestones of Cell Genesys across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Cell Genesys is founded.
- Funding First funding round of $310K.
- Exit Acquired by BioSante Pharmaceuticals.
Competitors of Cell Genesys
Cell Genesys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| jazzpharma.com | 2003 | Dublin, Ireland | $265M | 2,800 | Novel biopharmaceutical medicines are developed for unmet medical needs. | |
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| adacap.com | 2002 | Saint Genis Pouilly, France | $56.13M | – | Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | |
| incyte.com | 1991 | Wilmington, United States | – | 1,387 | Small molecules are developed for cancer and skin disease treatments. | |
| revmed.com | 2014 | Redwood, United States | $326.29M | 181 | Cancer therapies are developed using selective pathway inhibitors. | |
| blueprintmedicines.com | 2008 | Cambridge, United States | $115M | 201 | Selective kinase inhibitors are developed for genomically defined cancers. | |
| syndax.com | 2005 | Waltham, United States | $198.29M | 107 | Targeted therapies for cancer treatment are developed. | |
| c4therapeutics.com | 2016 | Cambridge, United States | $223M | 121 | Small-molecule drugs for cancer treatment are developed via Degronimid platform. |
Detailed competitors of Cell Genesys
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cell Genesys
Websites that share an audience with Cell Genesys (cellgenesys.com).
Websites whose visitors overlap most with Cell Genesys. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
prodoric.tu-bs.de | prodoric.tu-bs.de | 100% | – | – | – |
gene-regulation.com | gene-regulation.com | 100% | – | #3,341,613 | – |
rulai.cshl.edu | rulai.cshl.edu | 100% | – | – | – |
bioinformatics.ucla.edu | bioinformatics.ucla.edu | 100% | – | – | – |
horizonpress.com | horizonpress.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 16 similar websites and full traffic analytics for Cell Genesys
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 16 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Cell Genesys
10 companies that operate in the same segment as Cell Genesys (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cell Genesys
Cell Genesys was founded in 1988 and raised its 1st funding round 21 years after it was founded.
Cell Genesys is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Cell Genesys is a funded company, having raised a total of $310K across 1 funding round to date. The company's 1st funding round was a Unspecified of $310K, raised on Apr 2009.
Founded in 1988 in Hayward, United States, Cell Genesys operated in the biotechnology sector, focusing on cancer treatments. GVAX immunotherapies, consisting of modified irradiated tumor cells that secrete immune-stimulating cytokines, were advanced for prostate cancer, pancreatic cancer, and leukemia. Additionally, the oncolytic virus therapy CG0070 was developed in phase 1 trials for recurrent bladder cancer. The company was acquired by BioSante Pharmaceuticals in 2009.
Cell Genesys's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Cell Genesys has 1 investor. Key investors include Happy Family Store.
Cell Genesys operates through Cell Genesys Inc.
Yes. Cell Genesys was acquired by BioSante Pharmaceuticals in June 2009.